Back
Moderna, Inc. (MRNA)
BiotechnologyMRNA · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$68.26
−10.81%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$-7.25
ROE
-36.6%
Gross margin
-69.9%
Debt/Equity
0.18x
Revenue growth
260.2%
Moderna, Inc. — company intelligence
Earnings surprises
Q1 2026$-3.40 vs $-4.04 est+15.8%
Q4 2025$-2.11 vs $-2.70 est+21.7%
Q3 2025$-0.51 vs $-2.15 est+76.3%
Q2 2025$-2.13 vs $-3.03 est+29.6%
Analyst consensus · 30 analysts
4 Buy19 Hold7 Sell
Updated Jul 8, 2026
Insider activity · 90 days
12 buys14 sellsnet +49,309 shares
Banque Soria EsterBuy 18,658 · Jul 5, 2026
Banque Soria EsterBuy 38,364 · Jul 5, 2026
Mock James MSell 703 · Jul 2, 2026
Recent SEC filings
8-K — Material event reportJul 8, 2026
4 — Insider transaction reportJul 7, 2026
4 — Insider transaction reportJul 6, 2026
Latest news
Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know — Yahoo · 4d ago
Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%. What Gives? — Yahoo · 1w ago
Jim Cramer turns bullish on health care stock after years of doubt — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Moderna, Inc.
Weekly undervalued picks (like MRNA)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.